Krzysztof Mrózek, MD, PhD | Authors

Acute Myeloid Leukemia With Adverse Cytogenetic Risk

August 03, 2012

Acute myeloid leukemia (AML) encompasses multiple disease entities that differ with regard to marrow morphology, cytochemistry, immunophenotype, pretreatment clinical characteristics, and treatment outcome.